Developing a Novel Anti-Bcma CAR-T for Relapsed or Refractory Multiple Myeloma

被引：5

作者：

Yao, Xin ^{[1
]}

Zhu, Shigui ^{[1
]}

Huang, Jiaqi ^{[1
]}

Qu, Xiaoyan ^{[2
]}

Zhu, Judy ^{[1
]}

Wei, Yutian ^{[1
]}

Lan, Liping ^{[1
]}

Lv, Xiaoteng ^{[1
]}

Wu, Junfeng ^{[1
]}

Wang, Rirfei ^{[1
]}

Yang, Dingzhu ^{[1
]}

Zheng, Chengxiao ^{[1
]}

Zhao, DiJun ^{[1
]}

Fan, Lei ^{[2
]}

Huang, Fei ^{[2
]}

Lu, Hua ^{[2
]}

Zhang, Chaocan ^{[1
]}

Chen, Cheng ^{[1
]}

Li, Yanfeng ^{[1
]}

Ren, Jiaqiang ^{[1
]}

Zhang, Li ^{[1
]}

Humphries, Michael ^{[1
]}

Li, Jianyong ^{[2
]}

Yao, Yihong ^{[1
]}

机构：

[1] Cellular Biomed Grp Inc, Shanghai, Peoples R China

[2] Nanjing Med Univ, Jiangsu Prov Hosp, Dept Hematol, Affiliated Hosp 1, Nanjing, Peoples R China

来源：

BLOOD | 2019年 / 134卷

关键词：

D O I：

10.1182/blood-2019-125372

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：4

共 50 条

[1] Anti-BCMA CAR-T cell immunotherapy for relapsed or refractory multiple myeloma
Zhang, Xiaohui
Ouyang, Chenxi
Sun, Guofeng
Liu, Hongfeng
Qi, Junyuan
Suo, Xiaohui
EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2023, 26 (04)
[2] Overview of anti-BCMA CAR-T immunotherapy for multiple myeloma and relapsed/refractory multiple myeloma
Feng, Deming
Sun, Jian
SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2020, 92 (02)
[3] An alternative fully human anti-BCMA CAR-T shows response for relapsed or refractory multiple myeloma with anti-BCMA CAR-T exposures previously
Wang, Qingming
Wei, Runhong
Guo, Shufang
Min, Chao
Zhong, Xiong
Huang, Hui
Cheng, Zhi
CANCER GENE THERAPY, 2024, 31 (01) : 108 - 118
[4] An alternative fully human anti-BCMA CAR-T shows response for relapsed or refractory multiple myeloma with anti-BCMA CAR-T exposures previously
Qingming Wang
Runhong Wei
Shufang Guo
Chao Min
Xiong Zhong
Hui Huang
Zhi Cheng
Cancer Gene Therapy, 2024, 31 : 420 - 426
[5] Cardiovascular adverse events and outcomes after anti-BCMA CAR-T for relapsed and refractory multiple myeloma
Stefanie Palfi
Lauren C. Peres
Himara Koelmeyer
Melissa Alsina
Rachid C. Baz
Brandon J. Blue
Salvatore Corallo
Gabriel De Avila
Ciara Freeman
Rebecca Gonzalez
Ariel Grajales-Cruz
Kristy Harvey
Hien D. Liu
Taiga Nishihori
Guilherme H. Oliveira
Laura B. Oswald
Omar Castaneda Puglianini
Sruthi Selvakumar
Alexis Behne Sharma
Elicia Wang
Kenneth H. Shain
Michael Jain
Frederick L. Locke
Mohammed Alomar
Doris K. Hansen
Dae Hyun Lee
Blood Cancer Journal, 15 (1)
[6] Anti-BCMA CAR-T Cell Therapy in Relapsed or Refractory Multiple Myeloma Patients with Impaired Renal Function
He, Shao-long
Cheng, Yu-hang
Wang, Di
Xu, Meng-lei
Que, Yi-mei
Xu, Yan-jie
Ma, Liang-ming
Li, Chun-rui
Zhou, Jian-feng
CURRENT MEDICAL SCIENCE, 2021, 41 (03) : 474 - 481
[7] Safety and Efficacy of Anti-Bcma CAR-T Cells for Relapsed/Refractory Multiple Myeloma: A Systematic Review of Literature
Khan, Israr
Rafae, Abdul
Javaid, Anum
Ahmed, Zahoor
Qadeer, Haifza Abeera
Khan, Sana Irfan
Dar, Abdul Jabbar
Khurshid, Qasim
Jaan, Ali
Khalid, Farhan
Aijaz, Zobia
Hashmi, Mydah Sajid
Malik, Mustafa Nadeem
Anwer, Faiz
BLOOD, 2020, 136
[8] Anti-BCMA CAR-T Cell Therapy in Relapsed or Refractory Multiple Myeloma Patients with Impaired Renal Function
Shao-long He
Yu-hang Cheng
Di Wang
Meng-lei Xu
Yi-mei Que
Yan-jie Xu
Liang-ming Ma
Chun-rui Li
Jian-feng Zhou
Current Medical Science, 2021, 41 : 474 - 481
[9] Lenalidomide enhances the efficacy of anti-BCMA CAR-T treatment in relapsed/refractory multiple myeloma: a case report and revies of the literature
Guoxing Zhao
Runhong Wei
Lei Feng
Yi Wu
Feng He
Mingxing Xiao
Zhi Cheng
Cancer Immunology, Immunotherapy, 2022, 71 : 39 - 44
[10] Lenalidomide enhances the efficacy of anti-BCMA CAR-T treatment in relapsed/refractory multiple myeloma: a case report and revies of the literature
Zhao, Guoxing
Wei, Runhong
Feng, Lei
Wu, Yi
He, Feng
Xiao, Mingxing
Cheng, Zhi
CANCER IMMUNOLOGY IMMUNOTHERAPY, 2022, 71 (01) : 39 - 44

← 1 2 3 4 5 →